Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management
KCT0002923Phase 4Completed
- Sponsor
- Cardiovascular Research Foundation
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor, clopidogrel in acute coronary syndrome (ACS), cardiac ischemia, coronary arteriosclerosis, cardiac morbidity, sponsored by Cardiovascular Research Foundation. Started Jul 2014; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
acute coronary syndrome (ACS)cardiac ischemiacoronary arteriosclerosiscardiac morbidity
Beyond the preview
Go deeper on KCT0002923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002923.